These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28656025)

  • 1. The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis.
    Massoud OI; Zein NN
    Gastroenterol Hepatol (N Y); 2017 May; 13(5):286-291. PubMed ID: 28656025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis.
    Karasu Z; Gurakar A; Kerwin B; Hulagu S; Jazzar A; McFadden R; Nour B; Sebastian A; Cassidy F; Stokes K; Van Thiel DH; Wright H
    Dig Dis Sci; 2000 Oct; 45(10):1971-6. PubMed ID: 11117569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis.
    Barney EJ; Little EC; Gerkin RD; Ramos AX; Kahn J; Wong M; Kolli G; Manch R
    Dig Dis Sci; 2012 Sep; 57(9):2430-7. PubMed ID: 22588242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Doppler ultrasonography for predicting improvement of platelet count after transjugular intrahepatic portosystemic shunt.
    Ansari-Gilani K; Seddigh Tonekaboni B; Nakamoto DA; Modaresi Esfeh J
    Gastroenterol Rep (Oxf); 2017 Nov; 5(4):305-308. PubMed ID: 27694618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt--a prospective, controlled study.
    Gschwantler M; Vavrik J; Gebauer A; Kriwanek S; Schrutka-Kölbl C; Fleischer J; Madani B; Brownstone E; Tscholakoff D; Weiss W
    J Hepatol; 1999 Feb; 30(2):254-9. PubMed ID: 10068105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?
    Jabbour N; Zajko A; Orons P; Irish W; Fung JJ; Selby RR
    Dig Dis Sci; 1998 Nov; 43(11):2459-62. PubMed ID: 9824134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in hematologic and hemostatic parameters after transjugular intrahepatic portosystemic shunt (TIPS) implantation].
    Papp M; Mezei G; Udvardy M; Altorjay I
    Orv Hetil; 2003 Jul; 144(27):1341-5. PubMed ID: 12908147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis.
    Lawrence SP; Lezotte DC; Durham JD; Kumpe DA; Everson GT; Bilir BM
    Dig Dis Sci; 1995 Jul; 40(7):1575-80. PubMed ID: 7628285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of TIPS on Splenic Volume and Thrombocytopenia.
    Liu J; Ma J; Yang C; Ye T; Meng J; Shi Q; Xiong B
    AJR Am J Roentgenol; 2021 Mar; 216(3):698-703. PubMed ID: 33439047
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of transjugular intrahepatic portosystemic shunt on secondary hypersplenism.
    Pursnani KG; Sillin LF; Kaplan DS
    Am J Surg; 1997 Mar; 173(3):169-73. PubMed ID: 9124620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients.
    Alvarez OA; Lopera GA; Patel V; Encarnacion CE; Palmaz JC; Lee M
    Am J Gastroenterol; 1996 Jan; 91(1):134-7. PubMed ID: 8561113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.
    Bucsics T; Lampichler K; Vierziger C; Schoder M; Wolf F; Bauer D; Simbrunner B; Hartl L; Jachs M; Scheiner B; Trauner M; Gruenberger T; Karnel F; Mandorfer M; Reiberger T
    Dig Dis Sci; 2022 Dec; 67(12):5693-5703. PubMed ID: 35301618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt.
    Zhao D; Zhang G; Wang M; Zhang C; Li J
    Clin Mol Hepatol; 2019 Jun; 25(2):210-217. PubMed ID: 30897897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study.
    Wong RJ; Ge J; Boike J; German M; Morelli G; Spengler E; Said A; Desai A; Couri T; Paul S; Frenette C; Verna EC; Goel A; Fallon M; Thornburg B; VanWagner L; Lai JC; Kolli KP
    J Vasc Interv Radiol; 2023 Aug; 34(8):1364-1371. PubMed ID: 37100199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study.
    Lafortune M; Martinet JP; Denys A; Patriquin H; Dauzat M; Dufresne MP; Colombato L; Pomier-Layrargues G
    AJR Am J Roentgenol; 1995 Apr; 164(4):997-1002. PubMed ID: 7726065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience.
    Buechter M; Manka P; Gerken G; Canbay A; Blomeyer S; Wetter A; Altenbernd J; Kahraman A; Theysohn JM
    Dig Dis; 2018; 36(3):218-227. PubMed ID: 29316565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can pretransplant TIPS be harmful in liver transplantation? A propensity score matching analysis.
    Matsushima H; Fujiki M; Sasaki K; Cywinski JB; D'Amico G; Uso TD; Aucejo F; David Kwon CH; Eghtesad B; Miller C; Quintini C; Hashimoto K
    Surgery; 2020 Jul; 168(1):33-39. PubMed ID: 32268937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
    Su AP; Cao SS; Le Tian B; Da Zhang Z; Hu WM; Zhang Y; Wang ZL; Babu SR; Hu T
    Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):53-9. PubMed ID: 22099870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
    Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
    Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.